>북미 E-임상 솔루션 시장, 제품별(전자 데이터 캡처 및 임상 시험 데이터 관리 시스템, 임상 시험 관리 시스템, 임상 분석 플랫폼, 케어 조정 의료 기록(CCMR), 무작위화 및 시험 공급 관리 , 임상 데이터 통합 플랫폼, 전자 임상 결과 평가 솔루션, 안전 솔루션, 전자 시험 마스터 파일 시스템, 규제 정보 관리 솔루션 및 기타), 제공 모드(웹 호스팅(주문형) 솔루션, 라이선스 엔터프라이즈(온프레미스) 솔루션 및 클라우드 기반(SAAS) 솔루션), 임상 시험 단계(1상, 2상, 3상 및 4상), 조직 규모(소규모 및 중규모 및 대규모), 사용자 장치(데스크톱, 태블릿, 핸드헬드 PDA 장치, 스마트폰 및 기타), 최종 사용자(제약 및 바이오제약 회사, 계약 연구 기관, 컨설팅 서비스 회사, 의료 기기 제조업체, 병원 및 학술 연구 기관) - 산업 동향 및 예측 2030년.
북미 E-Clinical Solutions 시장 분석 및 규모
북미 e-임상 솔루션 시장은 Oracle, IQVIA Inc., Dassault Systemes, Clario 등과 같은 많은 글로벌 기업으로 구성되어 있기 때문에 본질적으로 분산되어 있습니다. 이러한 기업의 존재는 지역 전체에서 시스템 서비스 및 소프트웨어에 대한 경쟁력 있는 가격을 제공합니다. 지역 및 국제 수준에서 이러한 기업이 존재하기 때문에 공급업체와 제조업체는 모든 예산에서 다양한 사양과 특성을 가진 제품을 제공합니다. 전자 데이터 캡처(EDC) 시스템과 클라우드 기반 채택이 증가함에 따라 시장 성장이 촉진되고 있습니다. 또한 환자 중심 임상 시험에 대한 집중이 커지면서 시장 성장이 촉진될 것으로 예상됩니다.
Data Bridge Market Research는 북미 e-clinical 솔루션 시장이 2030년까지 8,167.32백만 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 14.5%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.
보고서 메트릭 |
세부 |
예측 기간 |
2023년부터 2030년까지 |
기준 연도 |
2022 |
역사적 연도 |
2021 (사용자 정의 가능 2015-2020) |
양적 단위 |
수익 (단위: USD 백만) |
다루는 세그먼트 |
Product (Electronic Data Capture and Clinical Trial Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Care Coordination Medical Records (CCMR), Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premises) Solutions, and Cloud-Based (SAAS) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Small & Medium and Large), User Device (Desktop, Tablet, Handheld PDA Device, Smart Phone, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutes) |
Countries Covered |
U.S., Canada, and Mexico |
Market Players Covered |
Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systèmes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC., Anju, Castor., Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC., Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager, Datatrack Int., and IQVIA Inc among others |
Market Definition
The goal of e-clinical solutions is to revolutionize the field of clinical research. The clinical management organization is trying to improve the effectiveness, efficiency, and accessibility of clinical research data to treat patients more quickly. The idea behind the creation of eClinical Solutions was to pinpoint the problems with clinical research data, fix them, and offer creative solutions to make clinical trial data useful and simple to obtain, as well as to facilitate the standardization, reporting, and operation of the clinical research domain. The rising adoption and growing focus towards the e clinical solutions and software are expected to drive market growth.
The e-clinical solutions, such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF) systems, are software programs used in clinical research to manage clinical data. However, strict regulations and standards for the approval of clinical trial studies and product approvals are expected to restrain the market growth.
North America E-Clinical Solutions Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
Increasing R&D Activities and Corresponding Expenditure
R&D is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.
The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.
Improved Healthcare Infrastructure and Establishment of Advanced Laboratories
Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.
Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.
Opportunity
- Increasing Investments By Various Governments In Clinical Trials
Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The Defense Advanced Research Agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biological initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to act as market growth opportunities.
Restraint / Challenge
Data Safety and Privacy issues
Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.
Data breaches have been common since 2019, over 50 million electronic medical records have been hacked, and in 2021, the number of security breaches is predicted to increase from the previous year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is expected to restrain market growth.
Recent Developments
- In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe.
- In March 2023, Clarion launched a cloud-based Image Viewer to help the Sponsors and CR to see the images of their clinical trials. Previously, several nations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering.
North America E-Clinical Solutions Market Scope
North America e-clinical solutions market is segmented into six notable segments on the basis of product, delivery mode, clinical trial phase, organization size, user device, and end user.
The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.
Product
- Electronic Data Capture and Clinical Data Management Systems
- Clinical Trial Management Systems
- Clinical Analytics Platforms
- Care Coordination Medical Record (CCMR)
- Randomization and Trial Supply Management
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment Solutions
- Safety Solutions
- Electronic Trial Master File Systems
- Regulatory Information Management Solutions
- Others
On the basis of product, the market is segmented into electronic data capture and clinical data management, clinical trial management systems, clinical analytics platforms, care coordination medical record (CCMR), randomization and trial supply management, clinical data integration platforms, electronic clinical outcome assessment solutions, safety solutions, electronic trial master file systems, regulatory information management solutions, and others.
Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premises) Solutions
- Cloud-based (SAAS) Solutions
On the basis of delivery mode, the market is segmented into web-hosted ( on-demand) solutions, licensed enterprise (on-premises) solutions, and cloud-based (SAAS) solutions.
Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
On the basis of clinical trial phase, the market is segmented into phase I, phase II, phase III, and phase IV.
Organization Size
- Small & Medium
- Large
On the basis of organization size, the market is segmented into small & medium and large.
User Device
- Desktop
- Tablet
- Handheld PDA Device
- Smart Phone
- Others
On the basis of user device, the market is segmented into desktop, tablet, handheld PDA device, smart phone, and others.
End User
- Pharmaceutical and Biopharmaceutical companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
On the basis of end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutes.
North America E-Clinical Solutions Market Regional Analysis/Insights
The North America E-Clinical Solutions Market is analyzed, and market size information is based on product, delivery mode, clinical trial phase, organization size, user device, and end user.
The countries covered in this market report are U.S., Canada, and Mexico.
The U.S. is expected to dominate the North America region due to increasing investment in R&D for drug discovery and delivery and the presence of strong key players in the country.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Market Share Analysis
북미 e-임상 솔루션 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
북미 e-임상 솔루션 시장에서 활동하는 주요 기업으로는 Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systèmes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC., Anju, Castor., Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC., Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager, Datatrack Int., IQVIA Inc. 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S FIVE FORCES MODEL
4.2 ECOSYSTEMS ANALYSIS OF E-CLINICAL SOLUTIONS
4.3 USE CASES
5 VALUE CHAIN ANALYSIS
6 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES
7.2 RESTRAINTS
7.2.1 DATA SAFETY AND PRIVACY ISSUES
7.2.2 LACK OF SKILLED PROFESSIONALS
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES
7.3 OPPORTUNITIES
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS
7.4 CHALLENGES
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS
7.4.2 HIGH IMPLEMENTATION COSTS
8 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
8.7 SAFETY SOLUTIONS
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
8.9 CLINICAL DATA INTEGRATION PLATFORMS
8.1 CLINICAL ANALYTICS PLATFORMS
8.11 CARE COORDINATION MEDICAL RECORD (CCMR)
8.12 OTHERS
9 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
9.3 CLOUD-BASED (SAAS) SOLUTIONS
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
10 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
10.1 OVERVIEW
10.2 PHASE III
10.3 PHASE I
10.4 PHASE II
10.5 PHASE IV
11 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE
11.1 OVERVIEW
11.2 MEDIUM AND SMALL
11.3 LARGE
12 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE
12.1 OVERVIEW
12.2 DESKTOP
12.3 TABLET
12.4 SMART PHONE
12.5 HANDHELD PDA DEVICE
12.6 OTHERS
13 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY END USER
13.1 OVERVIEW
13.2 CONTRACT RESEARCH ORGANIZATIONS
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
13.4 MEDICAL DEVICE MANUFACTURERS
13.5 HOSPITAL
13.6 CONSULTING SERVICE COMPANIES
13.7 ACADEMIC RESEARCH INSTITUTES
14 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ORACLE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 DASSAULT SYSTEMES
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 CLARIO
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 VEEVA SYSTEMS
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 ARISNORTH AMERICA
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS
17.6 4G CLINICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ADVARRA.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANJU
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 CASTOR.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 DATATRAK INT.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 ECLINICAL SOLUTIONS LLC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 IQVIA INC
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 MAXISIT
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 MEDNET
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 MEDRIO, INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 MERATIVE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 OPENCLINICA, LLC
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PAREXEL INTERNATIONAL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 REALTIME SOFTWARE SOLUTIONS, LLC
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 SAAMA TECHNOLOGIES, LLC
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SIGNANT HEALTH
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 Y-PRIME, LLC.
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 THE COSTS OF IMPLEMENTATION ARE AS FOLLOWS, ACCORDING TO SIMPLETRIALS:
TABLE 2 ACCORDING TO ECLINICAL WORKS – ECLINICAL OFFERS TWO ENTERPRISE PRICING PACKAGES:
TABLE 3 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 10 U.S. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 U.S. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 12 U.S. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 13 U.S. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 14 U.S. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 15 U.S. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 CANADA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 17 CANADA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 18 CANADA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 19 CANADA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 20 CANADA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 21 CANADA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 MEXICO E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 23 MEXICO E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 24 MEXICO E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 25 MEXICO E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 26 MEXICO E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 27 MEXICO E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: NORTH AMERICA VS COUNTRY MARKET ANALYSIS
FIGURE 5 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA E- CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 11 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS AS WELL AS INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE, IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA E- CLINICAL SOLUTIONS MARKET FROM 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA E-CLINICAL SOLUTIONS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA E-CLINICAL SOLUTIONS MARKET
FIGURE 14 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2022
FIGURE 19 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2022
FIGURE 23 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2022
FIGURE 27 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2022
FIGURE 31 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2022
FIGURE 35 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 39 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 40 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 43 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.